Melvin B. Heyman, M.D., M.P.H.
- Professor of Pediatrics Chief, Division of Pediatric Gastroenterology, Hepatology and Nutrition Department of Pediatrics Director, Pediatric Inflammatory Bowel Disease Program
Education
UCLA School of Medicine 1976
Board Certifications
- American Board of Pediatrics, General Pediatrics, Pediatric Gastroenterology Subspecialty
Program Affiliations
- UCSF Center for Obesity, Assessment, Study and Treatment (COAST)
- Pediatric Inflammatory Bowel Disease Program
- Pedatric Transplant Program
Biography
Dr. Melvin B. Heyman, chief of pediatric gastroenterology, hepatology and nutrition at UCSF Benioff Children's Hospital, specializes in treating children with inflammatory bowel disease, including Crohn's disease and ulcerative colitis, and nutrition-related problems. He earned a medical degree at UCLA and completed a pediatric residency at Los Angeles County-University of Southern California Medical Center. He also completed postdoctoral training in nutrition, earned a master's degree in public health, and completed a fellowship in pediatric gastroenterology at UCLA. In 1981, he joined UCSF, where he organized the pediatric nutrition support service and established protocols for pediatric gastroenterology.
A UCSF professor of pediatrics, Dr. Heyman is chair of the executive committee of the Pediatric Gastroenterology and Nutrition section of the American Academy of Pediatrics. He also serves on many local and national committees, including the American Academy of Pediatrics' Task Force on Prevention of Obesity in School Health (POSH), and the National Board of the National PTA. Dr. Heyman has an active role in teaching at all levels. He is the principal investigator for the NIH Training Grant that funds the Training Program in Pediatric Gastroenterology and Nutrition at UCSF.
Research Overview
Dr. Heyman's research has been oriented towards clinical problems in pediatric patients with nutrition and/or gastroenterologic issues. He was one of the first investigators to reveal the importance of nutrition support in sickle cell anemia, helped to develop procedures in the diagnosis of hepatobiliary problems in infants, and has been actively pursuing novel treatments for children with inflammatory bowel disease and gastroesophageal reflux disease.
His research has been funded by the NIH, by foundation grants, and by pharmaceutical and formula industry support. His recent research has been evolving into investigation of obesity in infancy and in school age children. With other members of COAST, he is looking at the effects of acculturation in the Latino and the Chinese populations in San Francisco. He is also very actively involved in developing strategies to improve nutrition and physical activities in public schools.
Research & Funding
- Training Program in Pediatric Gastroenterology/NutritionSponsor: NIHSponsor ID: T32DK007762Funding Period:Aug 1998-Jun 2018Principal Investigator
- Studies in Children with Digestive DisordersSponsor: NIHSponsor ID: K24DK060617Funding Period:Jul 2002-Jun 2013Principal Investigator
- Pathologic Markers of Genetic Damage and Disease in IBDSponsor: NIHSponsor ID: R03DK063187Funding Period:Sep 2004-Jul 2008Principal Investigator
- PEDIATRIC CLINICAL RESEARCH CENTERSponsor: NIH/NCRRSponsor ID: M01RR001271Funding Period:Dec 1981-Mar 2007Co-Investigator
Clinical Trials
- Study ID: NCT04004611Start Date: May 2020Estimated Completion Date: Jul 2022Condition(s): Inflammatory Bowel Disease
- Study ID: NCT03196427Start Date: Jul 2018Estimated Completion Date: Jun 2025Condition(s): Inflammatory Bowel Disease, Crohn's Disease
- Study ID: NCT03105102Start Date: Apr 2018Estimated Completion Date: Jun 2026Condition(s): Crohn's Disease, Inflammatory Bowel Disease
- Study ID: NCT03290781Start Date: Apr 2018Estimated Completion Date: Nov 2021Condition(s): Inflammatory Bowel Disease
- Study ID: NCT03345823Start Date: Mar 2018Estimated Completion Date: Sep 2026Condition(s): Crohn's Disease, Inflammatory Bowel Disease
- Study ID: NCT03283085Start Date: Feb 2018Estimated Completion Date: Jun 2025Condition(s): Crohn's Disease, Inflammatory Bowel Disease
- Study ID: NCT03345849Start Date: Dec 2017Estimated Completion Date: Sep 2021Condition(s): Crohn's Disease, Inflammatory Bowel Disease
- Study ID: NCT03259308Start Date: Dec 2017Estimated Completion Date: Nov 2020Condition(s): Inflammatory Bowel Disease
- Study ID: NCT03345836Start Date: Nov 2017Estimated Completion Date: Jun 2021Condition(s): Crohn's Disease, Inflammatory Bowel Disease, Immunotherapy
- Study ID: NCT03138655Start Date: Nov 2017Estimated Completion Date: May 2020Condition(s): Inflammatory Bowel Disease, Crohn's Disease
- Study ID: NCT02403323Start Date: Jun 2015Estimated Completion Date: Oct 2025Condition(s): Crohn's Disease, Inflammatory Bowel Disease
- Study ID: NCT02394028Start Date: Mar 2015Estimated Completion Date: Aug 2021Condition(s): Crohn's Disease, Inflammatory Bowel Disease
- Study ID: NCT02118584Start Date: Sep 2014Estimated Completion Date: Aug 2025Condition(s): Inflammatory Bowel Disease
- Study ID: NCT02100696Start Date: May 2014Estimated Completion Date: Jul 2020Condition(s): Inflammatory Bowel Disease
- Study ID: NCT01536509Start Date: Feb 2012Estimated Completion Date: May 2016Condition(s): Crohn's Disease, Inflammatory Bowel Disease, Indeterminate Colitis
- Study ID: NCT00495521Start Date: Jun 2007Estimated Completion Date: Oct 2008Condition(s): Crohn's Disease, Inflammatory Bowel Disease
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 333
- Cuneo AA, Outram S, Marsac ML, Vendlinski S, Heyman MB, Ly N, von Scheven E, Perito ER. Medical traumatic stress in cystic fibrosis: A qualitative analysis. J Cyst Fibros. 2023 07; 22(4):763-771. View in PubMed
- Patel PV, Kao E, Stekol E, Heyman MB, Vu L, Verstraete SG. Evaluating the Relationship Between Nutrition and Post-colectomy Pouchitis in Pediatric Patients with Ulcerative Colitis. Dig Dis Sci. 2023 06; 68(6):2188-2195. View in PubMed
- Verburgt CM, Dunn KA, Otley A, Heyman MB, Verstraete S, Sunseri W, Sylvester F, de Meij T, Comeau A, Langille M, de Jonge WJ, Benninga MA, Van Limbergen JE. Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study. BMJ Open. 2023 02 01; 13(2):e064944. View in PubMed
- Cuneo AA, Abu-El-Haija M, Marsac ML, Verstraete S, Heyman MB, Ly N, Perito ER. Pediatric Medical Traumatic Stress in Inflammatory Bowel Disease, Pancreatitis, and Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2022 10 01; 75(4):455-461. View in PubMed
- Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):64-69. View in PubMed
- View All Publications